Collaborations & Alliances
-
Collaborations & Alliances
OncoMed Earns $72.5M Celgene Milestones
Achieves safety data and clinical candidate designation01.05.16
-
Collaborations & Alliances | Validation
G3, Sanofi Partner to Identify Heart Disease Targets
Aims to identify new signaling pathways in atherosclerotic cardiovascular diseases01.05.16
-
Collaborations & Alliances | Logistics | Serialization | Supply Chain
Avid, Adents Partner on Serialization Capabilities
Combines software expertise and implementation know how01.05.16
-
Collaborations & Alliances
Merck KGaA, Pfizer Partner with Syndax on Cancer Drug Combo
To evaluate avelumab in combination with Syndax’s entinostat in ovarian cancer01.04.16
-
Collaborations & Alliances
Fibrocell, Intrexon in Degenerative Disease Alliance
Will combine fibroblast platform with Intrexon’s cellular engineering capabilities to generate cell-based therapeutics01.04.16
-
Collaborations & Alliances
Baxalta, Symphogen in Strategic Immuno-oncology Alliance
Aims to advance novel therapeutics against six checkpoint targets01.04.16
-
Collaborations & Alliances
Immune Licenses Bispecific Antibody Technology
New technology will allow for the development of drug candidates targeting immune checkpoints12.28.15
-
Collaborations & Alliances | Industry News
Bayer, CRISPR Therapeutics Establish JV
To develop and commercialize therapeutics for blood disorders, blindness, and congenital heart disease12.23.15
-
Collaborations & Alliances | Validation
Ionis Earns $5M Biogen Milestone
Validates target to treat an undisclosed neurological disorder12.23.15
-
Collaborations & Alliances
Lion Bio Enters Collab with MedImmune
Research to focus on novel immuno-oncology combination therapies12.21.15
-
APIs | Collaborations & Alliances | Custom Sourcing News
Codexis, Merck Extend Enzyme Supply Pact
To license and supply enzyme used in the manufacturing process for sitagliptin12.18.15
-
Collaborations & Alliances
TWi Biotech Forms Agreement with Castle Creek Pharma
To advance its drug candidate AC-203 for epidermolysis bullosa12.17.15
-
Bio News | cGMP Manufacture | Collaborations & Alliances | Facilities | Scale-up/Technology Transfer
AstraZeneca, WuXi Form Strategic Bio-alliance in China
Aims to expedite development of AZ's innovative biologics portfolio12.16.15
-
Collaborations & Alliances
Neovacs Signs Strategic Partnering Agreement
Will license technology to Korean company CKD Pharmaceutical12.15.15
-
Collaborations & Alliances
AMRI, Multispan in Drug Discovery Services Pact
Alliance aims to increase success in GPCR drug discovery12.14.15
-
Collaborations & Alliances
Inception IBD, Celgene in Strategic R&D Alliance
To discover and develop therapeutics for ulcerative colitis and Crohn’s disease12.14.15
-
Collaborations & Alliances
BMS, Princeton in Molecular Synthesis Alliance
Will establish chemistry research center to foster scientific exchange12.09.15
-
Collaborations & Alliances
-
Collaborations & Alliances
Charles River Expands MJFF Parkinson’s Pact
Aims to further advance efforts to identify novel small molecule LRRK2 inhibitors12.08.15
-
Collaborations & Alliances
Cypralis, Janssen in Neurodegenerative Pact
Aims to develop new cyclophilin inhibitors for neurodegenerative diseases12.07.15
